Your browser doesn't support javascript.
loading
Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network.
Gillespie, Brenda W; Laurin, Louis-Philippe; Zinsser, Dawn; Lafayette, Richard; Marasa, Maddalena; Wenderfer, Scott E; Vento, Suzanne; Poulton, Caroline; Barisoni, Laura; Zee, Jarcy; Helmuth, Margaret; Lugani, Francesca; Kamel, Margret; Hill-Callahan, Peg; Hewitt, Stephen M; Mariani, Laura H; Smoyer, William E; Greenbaum, Larry A; Gipson, Debbie S; Robinson, Bruce M; Gharavi, Ali G; Guay-Woodford, Lisa M; Trachtman, Howard.
Afiliación
  • Gillespie BW; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Laurin LP; Division of Nephrology, Maisonneuve-Rosemont Hospital, Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Zinsser D; Arbor Research Collaborative for Health, Ann Arbor, MI, 48104, USA.
  • Lafayette R; Stanford University Medical Center, Stanford, CA, 94305, USA.
  • Marasa M; Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Wenderfer SE; Pediatrics-Renal, Baylor College of Medicine, Houston, TX, USA.
  • Vento S; NYU Langone Health, Department of Pediatrics, Division of Nephrology, New York, NY, USA.
  • Poulton C; Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Barisoni L; Department of Pathology, Division of AI and Computational Pathology, Department of Medicine, Division of Nephrology, Duke University, Durham, NC, USA.
  • Zee J; Arbor Research Collaborative for Health, Ann Arbor, MI, 48104, USA.
  • Helmuth M; Arbor Research Collaborative for Health, Ann Arbor, MI, 48104, USA.
  • Lugani F; Laboratory of Molecular Nephrology, Istituto Giannina Gaslini, IRCCS, Genoa, Italy.
  • Kamel M; Emory University, Department of Pediatrics, Division of Nephrology, Atlanta, GA, USA.
  • Hill-Callahan P; Arbor Research Collaborative for Health, Ann Arbor, MI, 48104, USA.
  • Hewitt SM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Mariani LH; University of Michigan, Division of Nephrology, Ann Arbor, MI, USA.
  • Smoyer WE; Center for Clinical and Translational Research, the Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
  • Greenbaum LA; Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • Gipson DS; University of Michigan, Division of Nephrology, Department of Pediatrics, Ann Arbor, MI, USA.
  • Robinson BM; Arbor Research Collaborative for Health, Ann Arbor, MI, USA.
  • Gharavi AG; Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
  • Guay-Woodford LM; Center for Translational Research, Children's National Hospital, Washington, DC, USA.
  • Trachtman H; NYU Langone Health, Department of Pediatrics, Division of Nephrology, New York, NY, USA.
Contemp Clin Trials Commun ; 22: 100749, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33851061
ABSTRACT

BACKGROUND:

High data quality is of crucial importance to the integrity of research projects. In the conduct of multi-center observational cohort studies with increasing types and quantities of data, maintaining data quality is challenging, with few published guidelines.

METHODS:

The Cure Glomerulonephropathy (CureGN) Network has established numerous quality control procedures to manage the 70 participating sites in the United States, Canada, and Europe. This effort is supported and guided by the activities of several committees, including Data Quality, Recruitment and Retention, and Central Review, that work in tandem with the Data Coordinating Center to monitor the study. We have implemented coordinator training and feedback channels, data queries of questionable or missing data, and developed performance metrics for recruitment, retention, visit completion, data entry, recording of patient-reported outcomes, collection, shipping and accessing of biological samples and pathology materials, and processing, cataloging and accessing genetic data and materials.

RESULTS:

We describe the development of data queries and site Report Cards, and their use in monitoring and encouraging excellence in site performance. We demonstrate improvements in data quality and completeness over 4 years after implementing these activities. We describe quality initiatives addressing specific challenges in collecting and cataloging whole slide images and other kidney pathology data, and novel methods of data quality assessment.

CONCLUSIONS:

This paper reports the CureGN experience in optimizing data quality and underscores the importance of general and study-specific data quality initiatives to maintain excellence in the research measures of a multi-center observational study.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Contemp Clin Trials Commun Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...